非酒精性脂肪肝
法尼甾体X受体
医学
疾病
慢性肝病
脂肪肝
生物信息学
药理学
生物
内科学
生物化学
肝硬化
核受体
转录因子
基因
作者
Jing Sun,Xiuli Jin,Yiling Li
标识
DOI:10.3892/ijmm.2024.5412
摘要
Nonalcoholic fatty liver disease (NAFLD), the most common chronic hepatic disease, has become a leading health problem worldwide. The present review summarized the methods and mechanisms to treat NAFLD, including the Mediterranean diet, physical activity and exercise, bariatric surgery and specific therapeutic agents, including statins, peroxisome proliferator‑activated receptor agonists, cenicriviroc and farnesoid X receptor agonists. Biologically active substances, such as peptides, alkaloids, polyphenolic compounds, silymarin, antibiotics, fatty acids, vitamins, probiotics, synbiotics and lamiaceae have also demonstrated actions that combat NAFLD. Considering their different mechanisms of action, combining some of them may prove an efficacious treatment for NAFLD. In this light, the present review describes recent progress and future prospects in treating NAFLD.
科研通智能强力驱动
Strongly Powered by AbleSci AI